Are diabetics competing with celebs for Ozempic?

We’re sorry, but something went wrong while fetching your podcast feeds. Please contact us at for help.

Episode Notes

The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?

Guest: Matthew Schneier, feature writer for New York Magazine.

Host: Lizzie O’Leary

If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at to help support our work.

Podcast production by Evan Campbell